IsraelLawMost foreign companies buying an Israeli business know they need to satisfy the seller's lawyers, transfer title at the Land Registry or Companies Registrar, and navigate Israel's tax implications. Far fewer factor in Israel's merger control rules in time. The oversight is understandable: Israel is a small country, and many acquirers assume that regulators only care about deals reshaping large domestic markets. That assumption has caught international buyers off guard more than once.
Israel's merger control regime under the Economic Competition Law 5748-1988 (formerly the Restrictive Trade Practices Law, renamed in 2019) catches a wider range of deals than most foreign counsel expect. The thresholds are turnover-based, not market-share based, which means even a transaction between parties with no obvious competitive overlap can require a notification if their Israeli revenues are large enough. The ICA has around 100 staff in 2026, which is small by global standards, but it has pursued enforcement against purely cross-border transactions where parties assumed Israeli jurisdiction simply did not reach them.
This guide explains the full framework: what a "merger" means under Israeli law, when notification is mandatory, how the filing and review process works, and what happens when parties close without clearance.
1. What Is Merger Control in Israel?
Israel's merger control rules sit within the Economic Competition Law 5748-1988, administered by the Israel Competition Authority. The ICA's director general heads a body with three distinct functions: investigating cartel and abuse-of-dominance conduct, advising on regulations and exemptions, and reviewing proposed mergers before they close. This guide addresses only the third function.
The core obligation is a pre-closing standstill: parties to a notifiable merger must file a notification form with the ICA and wait for approval (or the expiry of the review period) before closing. There is no gun-jumping exception for urgent commercial reasons. Once the review clock starts running, the parties may not close the transaction, transfer any shares or assets covered by the merger, or take any step that would give one party de facto control over the other.
Notification is mandatory rather than voluntary. Israel does not operate a voluntary pre-notification advisory process. Either the thresholds are met, notification is required, and closing is prohibited until clearance is granted, or the thresholds are not met and no filing is needed. There is no middle ground where parties can choose to notify "just in case."
2. What Counts as a "Merger" Under Israeli Law?
Section 1 of the Economic Competition Law defines a merger broadly. The following transaction types are covered:
- Full acquisitions: The acquisition of all or substantially all of the assets or business of one company by another — including asset purchases structured as carve-outs from a larger group.
- Share acquisitions reaching a control threshold: Any transaction that gives the acquirer control (*shlitta*) over the target. "Control" under the Law means holding more than 50% of the votes or having the power to appoint the majority of the board. A share acquisition that takes a buyer from 30% to 51% is a merger; one that takes them from 51% to 80% is not a new merger because control was already established.
- Acquisitions of significant influence: Even without majority control, an acquisition of more than 25% of a company's shares or voting rights, or any stake that gives the buyer the ability to block ordinary resolutions, may constitute a "merger" if combined with other factors pointing to effective influence over competitive behaviour. The ICA has interpreted this category expansively.
- Full-function joint ventures: The creation of a joint venture that operates as an independent economic entity on a lasting basis — meaning it has its own management, staff, and revenues separate from its parents — is treated as a merger of the parent companies' activities in the JV's market. A contractual collaboration that does not create a standalone entity is typically not a merger, though it may raise separate cartel issues.
- Intra-group transactions: Transactions between companies that are already under common control are generally excluded from the merger notification requirement because they do not alter the competitive structure of the market. A holding company reorganising its wholly owned subsidiaries needs no ICA notification.
A common mistake: buying 24% of an Israeli company today and then purchasing a further 5% eighteen months later, assuming each tranche individually falls below the 25% significance threshold. Under Section 21(b) of the Economic Competition Law, the ICA looks at related acquisitions within a 24-month rolling window. Two acquisitions that each give less than 25% are aggregated if they form part of a coordinated plan, and the combined stake is evaluated as a single merger at the time of the second acquisition. Foreign buyers who have taken minority positions in Israeli companies as a precursor to full takeovers — a common private equity approach — regularly discover this rule only when the ICA contacts them. The prudent approach: seek ICA guidance informally before the second acquisition if the cumulative stake will approach or exceed 25%.
3. The Notification Thresholds
A merger is notifiable only if both of the following conditions are met, calculated in the fiscal year preceding the transaction:
- Aggregate Israeli turnover test: The combined annual revenues in Israel of all merging parties exceed NIS 414.01 million.
- Per-party Israeli turnover test: At least two of the merging parties each have annual revenues in Israel exceeding NIS 22.51 million.
Both tests must be satisfied simultaneously. A transaction where the combined Israeli revenues just exceed NIS 414 million but only one party has Israeli revenues above NIS 22.51 million does not trigger mandatory notification. Equally, a transaction where both parties exceed NIS 22.51 million each but the combined total is below NIS 414 million is not notifiable.
These thresholds were last formally updated by the Antitrust Regulations (Merger Notification) (Amendment) 5782-2022, which entered into force in March 2022, raising the per-party threshold from NIS 18 million to NIS 22.51 million and adjusting the aggregate threshold from NIS 360 million to NIS 414.01 million. The ICA reviews the figures periodically in light of inflation; practitioners should verify the current figures directly with the ICA or through updated regulations before any filing.
All thresholds are calculated on a group basis. "Group" means all entities controlled by or controlling the merging party, including sister companies, parent companies, and subsidiaries anywhere in the world that generate revenues from Israeli sales. A German parent's Israeli subsidiary revenues, the subsidiary's sub-subsidiaries, and any Israeli sales by other group entities all count.
"Revenues in Israel" under the ICA's guidelines means revenues derived from sales of goods or services to customers located in Israel, regardless of where the selling entity is incorporated or where the invoicing entity sits. A US technology company that licenses software to Israeli enterprises from a Delaware entity, billing in USD through a US account, generates revenues in Israel for threshold purposes if the customer is located in Israel. This catches many foreign-to-foreign deals involving tech, pharmaceutical, and industrial goods companies that sell into the Israeli market through distributors or direct sales teams without a formal Israeli subsidiary. The ICA's published guidance document "Calculating Turnover for Merger Notification" (updated 2023) sets out detailed rules on which revenues count, including treatment of pass-through revenues, value-added reselling, and financial services turnover.
4. The Local Presence Test for Foreign-to-Foreign Transactions
Israel's merger control rules apply extraterritorially when the parties have a sufficient connection to the Israeli market. The operative concept is "local presence" — a term developed through ICA practice rather than statutory definition.
A party has local presence in Israel if it (or a group member) has any of the following:
- An Israeli-registered subsidiary or affiliate;
- A registered branch office in Israel (*sניף*);
- A physical office, research centre, or representative office in Israel;
- An exclusive distributor or importer in Israel who sells the party's products as its principal commercial activity in the Israeli market.
The ICA has confirmed in published decisions that where both parties in a purely foreign deal have local presence as defined above, the notification obligation applies if the turnover thresholds are met — even if neither party is Israeli-owned and the deal closes in a foreign jurisdiction under foreign law. This principle was reinforced in the ICA's investigation of several European and US mega-mergers with Israeli subsidiaries in the 2020s, where parties filed in the US with the FTC/DOJ, the EU with the European Commission, and Israel with the ICA as parallel obligations.
Where only one merging party has Israeli presence, the ICA's position is that the notification obligation generally does not arise even if the combined group revenues would theoretically exceed the thresholds. This reflects the two-party element in the per-party test: you cannot satisfy the requirement that "at least two of the merging parties" exceed NIS 22.51 million each if only one party has Israeli revenues at all.
Foreign M&A teams sometimes discover the Israeli filing requirement late because their multi-jurisdictional merger control checklist was built around EU and US thresholds. The ICA does not automatically coordinate its review with the European Commission or the US FTC/DOJ; it runs an independent process on its own timeline. Phase I approvals in the EU and US do not bind the ICA, and the ICA can impose conditions that differ from those agreed with other regulators. For deals that also require Israeli notifications, the standard practice among experienced Israeli competition counsel is to file with the ICA at the same time as or slightly after the EU/US filings, and to build the Israeli review period into the overall deal timeline from the outset. Late Israeli filings after EU or US approval has been granted can create an embarrassing gun-jumping risk if parties have taken integration steps under the erroneous assumption that clearance everywhere had been obtained.
5. The ICA Filing Process
The formal notification is submitted to the ICA's merger control division using the ICA's official notification form (*form 2*). The form is available in Hebrew on the ICA website; the ICA accepts notification documents in Hebrew or English for multinational transactions, though all Hebrew-language regulatory materials are the authoritative version. In practice, large international transactions are filed in English with Hebrew translations of key documents.
A complete notification must include:
- Full corporate details and ownership structure of all merging parties, including the complete ownership chain up to ultimate beneficial owners;
- A description of the transaction and the transaction documents (share purchase agreement, asset purchase agreement, or JV agreement);
- Turnover data for each party by relevant product and geographic market for the two most recent fiscal years;
- A description of the parties' activities in Israel and any affected markets, with market share estimates where available;
- Copies of any internal documents (board minutes, presentations, due diligence reports) prepared by or for senior management that discuss the transaction's competitive effects in Israel;
- Contact details for counsel authorised to receive ICA correspondence.
The filing fee payable to the ICA is NIS 5,340 (2026 rate), paid by bank transfer to the ICA's account before or at the time of notification. This is separate from any legal or translation costs.
The ICA clock starts running from the date it receives a notification it considers complete (*hazmana shelemah*). If the ICA determines that the filing is deficient — missing documents, unclear market data, incomplete ownership disclosure — it will send a deficiency notice (*hodzaat pegam*) and the clock stops until the deficiency is corrected. Parties regularly underestimate how demanding the ICA can be on ownership structure disclosure, particularly for complex private equity fund structures with multiple GP and LP entities.
ICA Form 2 requires parties to disclose all "strategic or business planning documents" prepared within 24 months of the notification date that discuss the transaction's strategic rationale, competitive positioning, or market analysis — not just documents specifically prepared for the deal. This sweeps in board presentations prepared to evaluate whether to enter a new Israeli market, marketing decks describing the competitive landscape in Israel, and internal emails discussing Israeli competitors. The ICA treats these documents seriously and has used them as the basis for Phase II investigations in several cases where the external narrative of the deal differed from the internal one. The practical advice: run a document review specifically focused on Israeli market analysis materials before filing. If an internal document describes the acquisition as a way to eliminate a competitor's Israeli operations, the notification strategy must account for how the ICA will read that language.
6. Phase I and Phase II Timelines
Israeli merger control runs a two-phase structure similar to the EU system, though with shorter statutory deadlines.
Phase I — the standard 30-day review
After receiving a complete notification, the ICA director general has 30 calendar days to issue one of three decisions:
- Unconditional approval: The deal is cleared without conditions. Closing can proceed immediately.
- Conditional approval: Approval is granted subject to behavioural or structural conditions negotiated with the parties. If the parties accept the conditions, closing can proceed.
- Phase II opening: The ICA notifies the parties that the merger requires further in-depth review under Section 21A of the Economic Competition Law.
If the ICA does not issue any decision within 30 days from receipt of a complete notification, approval is deemed granted automatically by default (*hitnatzlut hameshuteket*). This deemed approval provision is important: parties sometimes worry that silence from the ICA means the filing is stuck, but the 30-day clock continues to run regardless, and non-action constitutes approval.
In practice, the vast majority of notified mergers — approximately 90% or more in recent years — are cleared in Phase I, often within 10 to 20 business days for straightforward transactions where the parties' Israeli market activities do not overlap.
Phase II — the in-depth review
When the ICA opens Phase II, it conducts a detailed market investigation. This includes:
- Formal information requests (*bakshashot meida*) sent to the merging parties and to competitors, customers, and suppliers in the affected Israeli markets;
- Market-share analysis, competitive constraints analysis, and often econometric modelling of price effects;
- Meetings with the parties' management and external economists;
- A preliminary position paper sent to the parties before the ICA's final decision, giving them the opportunity to respond.
The total review period in Phase II is 150 calendar days from the original notification date (not from the Phase II opening). This clock stops when the ICA sends an information request and does not restart until the requested information is delivered — a mechanism that can effectively extend the review period substantially if parties are slow to respond or if the ICA sends multiple rounds of requests.
At the end of Phase II, the director general can unconditionally approve, conditionally approve, or file an application with the Competition Tribunal (*beit ha-din latotzaot*) to prohibit the merger. The Competition Tribunal, a specialised quasi-judicial body with three-member panels of an economist, a legal expert, and a senior judge, then makes the final determination. Appeals from the Competition Tribunal lie to the Supreme Court.
The ICA typically approaches condition negotiations pragmatically. Structural remedies (divestitures) are preferred where the competitive concern is that the merged entity will control critical infrastructure, an input bottleneck, or a dominant Israeli brand. Behavioural remedies (supply obligations, price caps, access undertakings) are accepted where the concern is more about conduct than structure. The ICA has approved several large Israeli technology and healthcare acquisitions in Phase II with conditions requiring the merged entity to maintain separate competitive offerings for a defined period, to continue supplying Israeli competitors at regulated pricing, or to licence key IP to domestic rivals. Parties that bring in an Israeli competition economist before the ICA's preliminary position paper is issued come out ahead more often than those who wait for the paper before building a response. Once the preliminary paper is out, the ICA has months of staff analysis behind its position; making a credible counter-argument requires economic data that is genuinely difficult to pull together quickly once the clock is already running.
7. Prohibited Mergers and Structural Conditions
A merger is prohibited when the ICA determines it is likely to substantially lessen competition in any Israeli market — the standard test under Section 21(b) of the Economic Competition Law. The ICA will prohibit a merger (or seek a Competition Tribunal prohibition order) in the following scenarios:
- Creation or strengthening of a monopoly position: Under Section 26 of the Economic Competition Law, a company with more than 50% market share in any Israeli market is a "monopoly" and faces enhanced regulatory scrutiny. A merger that creates or reinforces a monopoly position faces the highest risk of prohibition.
- Horizontal mergers reducing competition below a threshold number of players: In markets with three or fewer significant competitors, the ICA scrutinises a deal that removes one player extremely closely. Israeli markets are often concentrated by global standards because of the country's relatively small size — a market position of 35% to 40% can already represent the number two or three competitor.
- Vertical mergers foreclosing access to key inputs: A merger between a dominant Israeli input supplier and one of its major customer-competitors can be prohibited or conditioned if it would give the merged entity the ability to foreclose rivals from accessing critical inputs.
Where the ICA applies conditions, the most common structural remedy is requiring the selling party or the combined entity to divest a defined business line, brand, or distribution network in Israel within a specified period — typically 6 to 12 months after closing. The divested business must be sold to an ICA-approved purchaser who is capable of operating it as a genuine competitor.
8. Penalties for Closing Without Clearance
The penalties for jumping the gun are serious, and the ICA has imposed them. Under Section 20 of the Economic Competition Law, closing a notifiable transaction without obtaining ICA clearance constitutes a criminal offence. The consequences include:
- Corporate fines: Up to NIS 1.46 million per violation for each merging entity. Where the merger involved multiple subsidiaries and closing steps, each step can constitute a separate violation, multiplying the total exposure.
- Personal criminal liability: Directors and senior executives of the merging companies can face personal criminal prosecution with a maximum prison term of two years. The ICA does not automatically pursue personal liability for inadvertent non-filings, but for deliberate circumvention of the notification requirement the risk is real.
- Compulsory unwinding: Under Section 21(c), the ICA can apply to the Economic Affairs Court for an order requiring the parties to unwind the merger — separating the merged entities, restoring the pre-merger competitive structure, and potentially divesting assets. Unwinding orders are rare but have been issued in cases involving small Israeli market mergers that closed without notification and where the ICA later discovered the oversight.
- Regulatory scrutiny carryover: A company that has once closed without notification is placed on the ICA's watch list for future transactions. Subsequent mergers by the same group receive closer scrutiny at the filing stage.
The ICA does maintain a leniency-type approach for inadvertent non-filings: companies that self-report a failure to notify before the ICA discovers it independently receive more favourable treatment than those caught through third-party complaints or ICA market surveillance. Self-reporting immediately, before any further integration steps are taken, is the best mitigation available when a filing has been missed.
Foreign acquirers of Israeli technology companies routinely discover a second mandatory approval alongside the ICA notification: prior consent from the Israel Innovation Authority (IIA) under the Encouragement of Research, Development and Technological Innovation in Industry Law 5744-1984. If the target Israeli company received IIA R&D grants at any time and the acquisition constitutes a "change of control" or involves a transfer of the know-how developed with grant funding outside Israel, the buyer needs IIA Innovation Committee approval before closing. The IIA process takes 45 to 90 days and is independent of the ICA process. It can also require a payment to the IIA of 100% to 600% of the accumulated grant amount, depending on the transaction type and the acquirer's country. For Israeli tech companies, which overwhelmingly use IIA grants during early development stages, the combination of ICA merger clearance and IIA approval effectively creates a dual-track regulatory process — both running simultaneously, both with the potential to impose conditions, and both capable of delaying or blocking closing. Building both into the deal timeline from the outset avoids a situation where ICA clearance is obtained, the parties want to close, and IIA approval is still outstanding.